Specify a stock or a cryptocurrency in the search bar to get a summary
Sanofi India Limited
SANOFISanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH. Address: Sanofi House, Mumbai, India, 400072
Analytics
WallStreet Target Price
786 041.44 INRP/E ratio
29.4894Dividend Yield
2.47 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SANOFI
Dividend Analytics SANOFI
Dividend growth over 5 years
430 %Continuous growth
–Payout Ratio 5 years average
132 %Dividend History SANOFI
Stock Valuation SANOFI
Financials SANOFI
Results | 2019 | Dynamics |